Literature DB >> 24284372

Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease.

Michael Scharl1, Pascal Frei, Sandra M Frei, Luc Biedermann, Achim Weber, Gerhard Rogler.   

Abstract

Anal adenocarcinomas arising from perianal fistulae represent a rare complication in Crohn's disease (CD) patients. We have previously demonstrated the involvement of an epithelial-to-mesenchymal transition (EMT) in the pathogenesis of CD-associated fistulae. Although EMT has also been implicated in the development of colorectal and anal carcinoma, the molecular link from fistula to carcinoma is unclear. We present a case of a 48-year-old White woman who developed a mucinous anal adenocarcinoma originating from a perianal, CD-associated fistula 24 years after being diagnosed with CD. To characterize the expression of EMT-associated molecules in fistula and carcinoma tissue, immunohistochemical analysis for Snail1, Slug, β-catenin and E-cadherin was performed. A mucinous anal adenocarcinoma developed on a perianal fistula in a patient with long-standing CD. After neoadjuvant radiochemotherapy, the fistula-associated tumour was resected and the patient is presently in remission. Using immunohistochemical analysis, we detected a remarkable staining of the Slug transcription factor in transitional cells lining the fistula tract. This observation is unique to this 'carcinoma'-fistula: we had previously shown Slug expression in cells surrounding the fistula tract but not in transitional cells. Expression of Snail1, β-catenin and E-cadherin in this case was comparable with our previous findings. We describe a rare case of a CD fistula-associated adenocarcinoma within an area of squamous epithelium of the perianal area and an unusual expression pattern of EMT markers in this fistula. This case seems to underline the relevance of our previous findings demonstrating that EMT plays an important role for fistula pathogenesis and likely carcinogenesis in CD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24284372     DOI: 10.1097/MEG.0b013e32836371a2

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

Review 1.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

Review 2.  The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease.

Authors:  Michael Scharl; Ramona S Bruckner; Gerhard Rogler
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

3.  Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.

Authors:  Britta Siegmund; Roger M Feakins; Giorgos Barmias; Juliano Coelho Ludvig; Fabio Vieira Teixeira; Gerhard Rogler; Michael Scharl
Journal:  J Crohns Colitis       Date:  2015-12-17       Impact factor: 9.071

Review 4.  Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.

Authors:  Julián Panés; Jordi Rimola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-09       Impact factor: 46.802

Review 5.  Epithelial-mesenchymal transition in Crohn's disease.

Authors:  H Jiang; J Shen; Z Ran
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

6.  Total flavone of Abelmoschus manihot suppresses epithelial-mesenchymal transition via interfering transforming growth factor-β1 signaling in Crohn's disease intestinal fibrosis.

Authors:  Bo-Lin Yang; Ping Zhu; You-Ran Li; Min-Min Xu; Hao Wang; Li-Chao Qiao; Hai-Xia Xu; Hong-Jin Chen
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

7.  Magnetic resonance imaging findings of carcinoma arising from anal fistula: A retrospective study in a single institution.

Authors:  Xin Zhu; Tian-Shu Zhu; Dan-Dan Ye; Shao-Wei Liu
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

8.  Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells.

Authors:  Martin Leutenegger; Ramona Bruckner; Marianne R Spalinger; Silvia Lang; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Intest Dis       Date:  2018-07-10

Review 9.  Evaluation of animal models of Crohn's disease with anal fistula (Review).

Authors:  Shuangshuang Lu; Keyuan Zhu; Yongxin Guo; Enjing Wang; Jin Huang
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

10.  Anal Canal Adenocarcinoma in a Patient with Longstanding Crohn's Disease Arising From Rectal Mucosa that Migrated From a Previously Treated Rectovaginal Fistula.

Authors:  Taku Maejima; Toru Kono; Fumika Orii; Atsuo Maemoto; Shigeru Furukawa; Wang Liming; Shoji Kasai; Susumu Fukahori; Nobutaka Mukai; Daitaro Yoshikawa; Hidenori Karasaki; Hiroya Saito; Kazuo Nagashima
Journal:  Am J Case Rep       Date:  2016-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.